Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cizeau

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Mutation Research|November 1, 1994
Deletions induced in the white and vermilion genes of Drosophila melanogaster by the antitumor drug cis-dichlorodiammineplatinum(II)J Cizeau, M Decoville, M Leng, et al.
Mutation Research|September 23, 1996
Large deletions induced in the white gene of Drosophila melanogaster by the antitumoral drug cis-dichlorodiammineplatinum(II): influence of non-homologous recombinationJ Cizeau, M Decoville, M Leng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSAE Girou, G Pujade, P Legrand, et al.
Protein Expression and Purification|March 23, 2011
Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentationArjune Premsukh, Joelle M Lavoie, Jeannick Cizeau, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 4, 2012
Preclinical evaluation of VB6-845: an anti-EpCAM immunotoxin with reduced immunogenic potentialJoycelyn Entwistle, Jennifer G Brown, Shilpa Chooniedass, et al.
Oncogene|December 15, 2000
The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanismJ Cizeau, R Ray, G Chen, et al.
Intensive Care Medicine|October 18, 2005
Should electronic faucets be used in intensive care and hematology units?Jacques Merrer, Emmanuelle Girou, David Ducellier, et al.
Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics|April 24, 2002
Statistical properties of the volatility of price fluctuationsY Liu, P Gopikrishnan, P Cizeau, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Engineering and biological characterization of VB6-845, an anti-EpCAM immunotoxin containing a T-cell epitope-depleted variant of the plant toxin bouganinJeannick Cizeau, Danielle M Grenkow, Jennifer G Brown, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2009
Preclinical assessment of an anti-EpCAM immunotoxin: locoregional delivery provides a safer alternative to systemic administrationJennifer Brown, Michele Rasamoelisolo, Maureen Spearman, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Mutation Research|November 1, 1994
Deletions induced in the white and vermilion genes of Drosophila melanogaster by the antitumor drug cis-dichlorodiammineplatinum(II)J Cizeau, M Decoville, M Leng, et al.
Mutation Research|September 23, 1996
Large deletions induced in the white gene of Drosophila melanogaster by the antitumoral drug cis-dichlorodiammineplatinum(II): influence of non-homologous recombinationJ Cizeau, M Decoville, M Leng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSAE Girou, G Pujade, P Legrand, et al.
Protein Expression and Purification|March 23, 2011
Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentationArjune Premsukh, Joelle M Lavoie, Jeannick Cizeau, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 4, 2012
Preclinical evaluation of VB6-845: an anti-EpCAM immunotoxin with reduced immunogenic potentialJoycelyn Entwistle, Jennifer G Brown, Shilpa Chooniedass, et al.
Oncogene|December 15, 2000
The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanismJ Cizeau, R Ray, G Chen, et al.
Intensive Care Medicine|October 18, 2005
Should electronic faucets be used in intensive care and hematology units?Jacques Merrer, Emmanuelle Girou, David Ducellier, et al.
Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics|April 24, 2002
Statistical properties of the volatility of price fluctuationsY Liu, P Gopikrishnan, P Cizeau, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Engineering and biological characterization of VB6-845, an anti-EpCAM immunotoxin containing a T-cell epitope-depleted variant of the plant toxin bouganinJeannick Cizeau, Danielle M Grenkow, Jennifer G Brown, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2009
Preclinical assessment of an anti-EpCAM immunotoxin: locoregional delivery provides a safer alternative to systemic administrationJennifer Brown, Michele Rasamoelisolo, Maureen Spearman, et al.
Pageof 4